Cargando…
Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study
INTRODUCTION: High-dose methotrexate (HDMTX) is administered for the treatment of some cancers. HDMTX is usually safe but may crystallize in renal tubules causing acute kidney injury (AKI). Consequently, MTX elimination is delayed, resulting in a severe and life-threatening condition. No studies hav...
Autores principales: | Gros, Luis, Roldán, Alicia, Cabero-Martínez, Almudena, Domínguez-Pinilla, Nerea, de la Fuente, Adolfo, González-Barca, Eva, Tasso, María, Torrent, Montserrat, Gallardo, Eva, del Cerro, Inés, Giró-Perafita, Ariadna, Badia, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273868/ https://www.ncbi.nlm.nih.gov/pubmed/35147457 http://dx.doi.org/10.1177/10781552221079568 |
Ejemplares similares
-
Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer
por: Giró-Perafita, Ariadna, et al.
Publicado: (2017) -
EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models
por: Giró-Perafita, Ariadna, et al.
Publicado: (2019) -
A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria
por: Ferrer, Ricard, et al.
Publicado: (2022) -
Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate
por: Yang, Shi-Long, et al.
Publicado: (2015) -
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
por: Blancafort, Adriana, et al.
Publicado: (2015)